HOME > LATEST
LATEST
-
BUSINESS Vimpat Copies Hit Shelves at 35% of Originator Price as 10 Firms Flock to Market
December 5, 2025
-
REGULATORY Another LDP Study Group Submits Emergency Proposal Urging Drug Pricing Overhaul
December 5, 2025
-
REGULATORY Ishin Urges Takaichi to Revisit OTC-Like Drug Coverage, Softens Savings Target
December 5, 2025
-
REGULATORY JPMA Chief Presses LDP Study Group to Lock In On-Patent Prices, Scrap “Spillover” Rule
December 5, 2025
-
REGULATORY LDP, Ishin to Continue OTC-Like Drug Talks on “Special Charge” Design
December 5, 2025
-
REGULATORY Forxiga, Zytiga Seen Taking Biggest Hit by PMP Returns in FY2026
December 5, 2025
-
BUSINESS Keytruda Extends Japan Sales Lead to 26 Straight Months in November: Encise
December 5, 2025
-
BUSINESS Meiji Pharma Takes Stake in Lyric Bio to Back Next-Gen IVIg Manufacturing
December 5, 2025
-
BUSINESS PIII Win for Capricor’s DMD Cell Therapy Sets Stage for New FDA Try
December 5, 2025
-
REGULATORY Vimpat Draws 10 Generic Entrants in December Listing; Forxiga Has Two, but Nipro AG Absent
December 4, 2025
-
REGULATORY MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?
December 4, 2025
-
REGULATORY Bayer’s Eylea Bio-AG Finally Reaches NHI Listing amid Reform Talks
December 4, 2025
-
REGULATORY MHLW Panel Green-Lights Approval for Kissei’s Uterine Fibroid Drug, 3 More NMEs
December 4, 2025
-
REGULATORY MHLW Proposes Pricing New AGs and Bio-AGs on Par with Originators
December 4, 2025
-
REGULATORY FY2026 Reform Roadmap Keeps Key Drug Pricing Issues on Ice, Snubs Many Industry Requests: Chuikyo
December 4, 2025
-
BUSINESS Novo Nordisk Launches Higher-Capacity Awiqli Pen in Japan
December 4, 2025
-
BUSINESS Daiichi Sankyo Wins US Appeal in Seagen ADC Patent Dispute
December 4, 2025
-
BUSINESS Vimpat Generics Win Added Use, Clearing Path for Full-Label Launch
December 4, 2025
-
REGULATORY LDP Tax Panel Puts R&D Tax Credit on Political-Judgment Track for Further Talks
December 3, 2025
-
ORGANIZATION Labor Union Group Submits Request, Urges Drug Pricing Overhaul amid Inflation
December 3, 2025
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
